![Darren Shafren](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Darren Shafren
Fundador en ImmVirX Pty Ltd. .
Perfil
Darren Shafren is the founder of ImmVirX Pty Ltd.
He is currently an Associate Professor at The University of Newcastle.
Previously, he served as the Chief Scientific Officer at Viralytics Pty Ltd.
from 2009 to 2019.
Cargos activos de Darren Shafren
Empresas | Cargo | Inicio |
---|---|---|
The University of Newcastle | Corporate Officer/Principal | - |
ImmVirX Pty Ltd.
![]() ImmVirX Pty Ltd. Miscellaneous Commercial ServicesCommercial Services ImmVirX Pty Ltd. develops oncotic viral immunotherapy. The Australian company was founded in 2019 by Malcolm L. McColl and Darren Shafren. Malcolm L. McColl has been the CEO since 2019. | Fundador | - |
Antiguos cargos conocidos de Darren Shafren.
Empresas | Cargo | Fin |
---|---|---|
VIRALYTICS LTD. | Director de Investigación - Acciones | 25/10/2009 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Viralytics Pty Ltd.
![]() Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
ImmVirX Pty Ltd.
![]() ImmVirX Pty Ltd. Miscellaneous Commercial ServicesCommercial Services ImmVirX Pty Ltd. develops oncotic viral immunotherapy. The Australian company was founded in 2019 by Malcolm L. McColl and Darren Shafren. Malcolm L. McColl has been the CEO since 2019. | Commercial Services |
- Bolsa de valores
- Insiders
- Darren Shafren